Statin dose in Asians: Is pharmacogenetics relevant?

Ping Wang

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


Historically the efficacy and safety of statins has mostly been studied in western populations. Few such studies have been carried out in Asians until recent years. These studies revealed interesting similarities and differences for statin use between Asians and Caucasians. One clinically important question subsequently raised is whether Asians need lower statin doses compared with Caucasians. Many practicing physicians believe that statin doses are lower in Asians because of the generally lower bodyweight and BMI. Whether this belief is based on sound scientific evidence needs to be reviewed. Furthermore, since the decision of optimal dose is based on both efficacy and safety, both of which may be impacted by genetic factors, one may ask whether pharmacogenetics plays a role in the dose difference, if such a difference exists. There is a clinical need to critically and comprehensively article the literature to answer these questions, and summarize future directions of research in the field. This article serves the above purpose.

Original languageEnglish (US)
Pages (from-to)1605-1615
Number of pages11
Issue number11
StatePublished - Nov 2011


  • Asians
  • dose
  • pharmacogenetics
  • statin

ASJC Scopus subject areas

  • Pharmacology
  • Genetics
  • Molecular Medicine


Dive into the research topics of 'Statin dose in Asians: Is pharmacogenetics relevant?'. Together they form a unique fingerprint.

Cite this